Efficacy and Safety of the Modified Cretan Protocol in Patients with Post-LASIK Ectasia

Turk J Ophthalmol. 2024 Jun 28;54(3):120-126. doi: 10.4274/tjo.galenos.2024.82342. Epub 2024 Jun 10.

Abstract

Objectives: To investigate the clinical efficacy and safety of the modified Cretan protocol in patients with post-laser in situ keratomileusis ectasia (PLE).

Materials and methods: In this retrospective study, 26 eyes of 16 patients with PLE were treated with the modified Cretan protocol (combined transepithelial phototherapeutic keratectomy and accelerated corneal collagen cross-linking). Visual, refractive, tomographic, and aberrometric outcomes and point spread function (PSF) were recorded preoperatively and at 6, 12, and 24 months after treatment.

Results: Both uncorrected and best corrected visual acuity were stable at 24 months postoperatively compared to baseline (from 0.89±0.36 to 0.79±0.33 logarithm of the minimum angle of resolution [LogMAR] and 0.31±0.25 to 0.24±0.19 LogMAR, respectively, p>0.05 for all values). The mean K1, K2, Kmean, thinnest corneal thickness, and spherical aberration at baseline were 45.76±5.75 diopters (D), 48.62±6.17 D, 47.13±5.89 D, 433.16±56.86 μm, and -0.21±0.63 μm respectively. These values were reduced to 42.86±6.34 D, 45.92±6.74 D, 44.21±6.4 D, 391.07±54.76 μm, and -0.51±0.58 μm at 24 months postoperatively (p<0.001, p=0.002, p<0.001, p=0.001, and p=0.02, respectively). The mean spherical equivalent, manifest cylinder, Kmax, central corneal thickness, other corneal aberrations (root mean square, trefoil, coma, quatrefoil, astigmatism), and PSF remained stable (p>0.05 for all variables), while anterior and posterior elevation were significantly improved at 24 months postoperatively (p<0.001 and p=0.02, respectively). No surgical complications occurred during the 24-month follow-up.

Conclusion: The modified Cretan protocol is a safe and effective treatment option for PLE patients that provides visual stabilization and significant improvement in topographic parameters during the 24-month follow-up. Further studies are needed to support our results.

Keywords: Post-LASIK ectasia; corneal collagen cross-linking; transepithelial phototherapeutic keratectomy; corneal topography.

MeSH terms

  • Adult
  • Collagen
  • Cornea / pathology
  • Cornea / surgery
  • Corneal Diseases / diagnosis
  • Corneal Diseases / etiology
  • Corneal Diseases / physiopathology
  • Corneal Diseases / surgery
  • Corneal Topography*
  • Cross-Linking Reagents* / therapeutic use
  • Dilatation, Pathologic / etiology
  • Female
  • Follow-Up Studies
  • Humans
  • Keratomileusis, Laser In Situ* / adverse effects
  • Keratomileusis, Laser In Situ* / methods
  • Lasers, Excimer / therapeutic use
  • Male
  • Myopia / physiopathology
  • Myopia / surgery
  • Photochemotherapy / methods
  • Photosensitizing Agents* / therapeutic use
  • Postoperative Complications / diagnosis
  • Refraction, Ocular* / physiology
  • Retrospective Studies
  • Riboflavin / therapeutic use
  • Treatment Outcome
  • Ultraviolet Rays
  • Visual Acuity*
  • Young Adult

Substances

  • Cross-Linking Reagents
  • Photosensitizing Agents
  • Collagen
  • Riboflavin